⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1042991 | 0.82 | — | — | |
| SCHEMBL12861370 | 0.82 | — | — | |
| SCHEMBL31518697 | 0.73 | TSHR (0.35) | — | |
| SCHEMBL31188955 | 0.70 | TSHR (0.33) | — | |
| SCHEMBL7198099 | 0.68 | TSHR (0.32) | — | |
| SCHEMBL8727419 | 0.67 | TDP1 (0.33) | — | |
| SCHEMBL8315395 | 0.67 | — | — | |
| SCHEMBL12432228 | 0.64 | — | — | |
| SCHEMBL18636865 | 0.64 | — | — | |
| SCHEMBL2498768 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 147 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9944755-B2 | Oxazoline polymer compositions and use thereof | ANP TECHNOLOGIES, INC. (US) | 2018-04-17 | — | — | US | claimed |
| US-20170066879-A1 | Oxazoline Polymer Compositions and Use Thereof | FULGENT GENETICS, INC. | 2017-03-09 | — | — | US | claimed |
| US-20160024252-A1 | Oxazoline Polymer Compositions and Use Thereof | ANP TECHNOLOGIES, INC. (US) | 2016-01-28 | — | — | US | claimed |
| WO-2013020005-A2 | OXAZOLINE POLYMER COMPOSITIONS AND USE THEREOF | ANP TECHNOLOGIES, INC. (US) | 2013-02-07 | — | — | WO | claimed |
| EP-2075011-A2 | Prodrugs Containing Bio-Cleavable Linkers | Piramal Life Sciences Limited (IN) | 2009-07-01 | — | — | EP | claimed |
| EP-3377504-B1 | CYCLAM BASED COMPOUNDS, THEIR CONJUGATES, CO-ORDINATION COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF, METHOD OF PREPARATION AND USE THEREOF | UNIV KARLOVA (CZ) | 2020-08-19 | — | — | EP | disclosed |
| US-10188605-B2 | Nanoparticles and nanoparticle compositions | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2019-01-29 | — | — | US | disclosed |
| US-20180289821-A1 | Oxazoline Polymer Compositions and Use Thereof | ANP TECHNOLOGIES, INC. (US) | 2018-10-11 | — | — | US | disclosed |
| EP-3377504-A1 | CYCLAM BASED COMPOUNDS, THEIR CONJUGATES, CO-ORDINATION COMPOUNDS, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, METHOD OF PREPARATION AND USE THEREOF | Univerzita Karlova (CZ) | 2018-09-26 | — | — | EP | disclosed |
| US-9944755-B2 | Oxazoline polymer compositions and use thereof | ANP TECHNOLOGIES, INC. (US) | 2018-04-17 | — | — | US | disclosed |
| US-20170202971-A1 | Oxazoline Polymer Compositions and Use Thereof | ANP TECH INC (US) | 2017-07-20 | — | — | US | disclosed |
| US-20170066879-A1 | Oxazoline Polymer Compositions and Use Thereof | FULGENT GENETICS, INC. | 2017-03-09 | — | — | US | disclosed |
| US-20060080791-A1 | Dyeing composition comprising at least one disulphide dye and method of dyeing human keratin fibers using this dye | L'OREAL S.A. (FR) | 2006-04-20 | — | — | US | disclosed |
| EP-1647580-A1 | Dying composition comprising a particular disulfide dye and process of dying keratinous fibres with this dye. | L'OREAL (FR) | 2006-04-19 | — | — | EP | disclosed |
| WO-2006027711-A2 | PRODRUGS AND CODRUGS CONTAINING BIO- CLEAVABLE DISULFIDE LINKERS | NICHOLAS PIRAMAL INDIA LIMITED (IN) | 2006-03-16 | — | — | WO | disclosed |
| US-20060046967-A1 | Prodrugs containing novel bio-cleavable linkers | Piramal Enterprises Limited (IN) | 2006-03-02 | — | — | US | disclosed |
| US-6630496-B1 | Antiinflammatory agents inhibit phospholipase 2, affecting both protaglandin and leukotriene production; indoles substituted in 2 position by 2,4-dioxo-thiazol-3-yl methylidene | GENETICS INSTITUTE LLC | 2003-10-07 | — | — | US | disclosed |
| EP-0251093-B1 | Production of antibody catalysts | IGEN INC (US) | 1994-08-17 | — | — | EP | disclosed |
| US-4792446-A | REACTION PRODUCT OF SUBSTRATE AND HAPTEN | IGEN, INC. (US) | 1988-12-20 | — | — | US | disclosed |
| EP-0251093-A2 | Production of antibody catalysts | IGEN, INC. (US) | 1988-01-07 | — | — | EP | disclosed |